Journal of Ovarian Research

Article	Citations
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective	76
The role of oxidative stress in ovarian aging: a review	69
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment	56
YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells	53
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age	50
Withaferin A: a potential therapeutic agent against COVID-19 infection	47
Therapeutic role of curcumin and its novel formulations in gynecological cancers	41
circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis	40
An overview of FSH-FSHR biology and explaining the existing conundrums	38
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis	37
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer	37
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized	35
Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS	35
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses	35
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis	34
MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer	33
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells	33
Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis	33
Whole-exome sequencing in patients with premature ovarian insufficiency: early detection and early intervention	33
Adipocytes: active facilitators in epithelial ovarian cancer progression?	32
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells	32
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer	30
Targeting purine metabolism in ovarian cancer	28
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A	28
Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models	27

Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging	27
Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells	26
LINC01094/miR-577 axis regulates the progression of ovarian cancer	26
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis	26
Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis	26
Association between morphologic grading and implantation rate of Euploid blastocyst	25
Comparison of methods for quantifying primordial follicles in the mouse ovary	24
Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients	24
The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal‐weight population	24
Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1	24
Prediction of the treatment response in ovarian cancer: a ctDNA approach	22
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression	22
Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study	22
Mechanisms of ovarian aging in women: a review	22
Transcriptomics of cumulus cells – a window into oocyte maturation in humans	22
Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1	21
Telomere length in granulosa cells and leukocytes: a potential marker of female fertility? A systematic review of the literature	21
RETRACTED ARTICLE: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis	20
Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice	20
Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR	19
Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis	19
The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients	19
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications	19
Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer	19
Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome	19
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer	19
Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors	19
Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses	18
Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer	18
miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcino	18
LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p	18
Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments	18
UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway	17
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?	17
CACNA1C is a prognostic predictor for patients with ovarian cancer	17
LncRNA HOTAIRM1, miR-433-5p and PIK3CD function as a ceRNA network to exacerbate the development of PCOS	17
RETRACTED ARTICLE: Long non-coding RNA PTPRG-AS1 promotes cell tumorigenicity in epithelial ovarian cancer by decoying microRNA-545-3p and consequently enhancing HDAC4 expression	16
Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism	16
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma	16
LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis	16
Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?	16
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer	16
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer	16
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review	16
Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis	16
Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis	16
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer	16
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status	16
p38β - MAPK11 and its role in female cancers	16
Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature	15

Role of different non-coding RNAs as ovarian cancer biomarkers	15
Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients	15
Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer	15
The role of MMP-14 in ovarian cancer: a systematic review	15
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer	15
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer	15
Age-related decline in the expression of GDF9 and BMP15 genes in follicle fluid and granulosa cells derived from poor ovarian responders	15
Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway	15
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer	15
Aged mice ovaries harbor stem cells and germ cell nests but fail to form follicles	14
Mutation analysis of the TUBB8 gene in primary infertile women with oocyte maturation arrest	14
A risk model of gene signatures for predicting platinum response and survival in ovarian cancer	13
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer	13
Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K	13
TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells	13
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study	13
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer	13
BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea	13
The boosting effects of melatonin on the expression of related genes to oocyte maturation and antioxidant pathways: a polycystic ovary syndrome- mouse model	13
Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-3	13
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer	13
Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer	12
Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients	12
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study	12
LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation	12
Comparison of dietary micronutrient intake in PCOS patients with and without metabolic syndrome	12
Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer	12
Association between atypical endometriosis and ovarian malignancies in the real world	12
RETRACTED ARTICLE: LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration	12
CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer	12
Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics	12
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing	12
Ovarian microcystic stromal tumor with omental metastasis: the first case report and literature review	12
Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA	12
Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study	12
Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer	12
miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF9	12
Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer	11
Lnc-GULP1–2:1 affects granulosa cell proliferation by regulating COL3A1 expression and localization	11
Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq	11
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer	11
Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network	11
Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis	11
Construction autophagy-related prognostic risk signature to facilitate survival prediction, individual treatment and biomarker excavation of epithelial ovarian cancer patients	11
MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF4	11
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer	11
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro	11
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report	11
miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B	11
MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD4	11
Predictive factors of endometriosis progression into ovarian cancer	11
Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis	11
Baicalin improves the functions of granulosa cells and the ovary in aged mice through the mTOR signaling pathway	10
Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway	10
LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-6	10
Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture	10
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present	10
Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis	10
LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer	10
Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI	10
Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome	10
A poor prognostic metastatic nongestational choriocarcinoma of the ovary: a case report and the literature review	10
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia	10
LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis	10
Trophectoderm biopsy of blastocysts for a preimplantation genetic test does not affect serum β-hCG levels in early pregnancy: a study using propensity score matching	10
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer	10
The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p	10
Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience	10
Effect of blastocyst morphology and developmental speed on transfer strategy for grade “C” blastocyst in vitrified‐warmed cycles	10
Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway in vitro	10
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer	10
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling	10
Clinical analysis and artificial intelligence survival prediction of serous ovarian cancer based on preoperative circulating leukocytes	10
Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer	10
Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors	9
Ovarian reserve in nigerian women with sickle cell anaemia: a cross- sectional study	9
WISP2 promotes cell proliferation via targeting ERK and YAP in ovarian cancer cells	9
Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China	9
Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats	9
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6	9

Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics	9
Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer	9
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy	9
Fertility care amidst the COVID19 pandemic: the American experience	9
Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey	9
GIMAP7 induces oxidative stress and apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inhibiting sonic hedgehog signalling pathway	9
ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis	9
Trends in incidence and mortality for ovarian cancer in China from 1990 to 2019 and its forecasted levels in 30 years	9
Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles	9
A flexible short protocol in women with poor ovarian response over 40 years old	9
FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization	9
Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation	9
The presence of living endometrial cells in ovarian endometriotic cyst fluid may contribute to the recurrence of endometriosis after surgical excision of endometriomas	9
Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome	9
Successful live birth in a Chinese woman with P450 oxidoreductase deficiency through frozen-thawed embryo transfer: a case report with review of the literature	9
Ovarian sex cord stromal tumours: analysis of the clinical and sonographic characteristics of different histopathologic subtypes	9
Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells	9
Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels	8
Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis	8
Amniotic fluid-derived exosomes attenuated fibrotic changes in POI rats through modulation of the TGF-β/Smads signaling pathway	8
microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway	8
Troxerutin protects against DHT-induced polycystic ovary syndrome in rats	8
LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis	8
Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors	8
Association between the food security status and dietary patterns with polycystic ovary syndrome (PCOS) in overweight and obese Iranian women: a case-control study	8
Laser-assisted hatching in lower grade cleavage stage embryos improves blastocyst formation: results from a retrospective study	8
The effect of prophylactic bilateral salpingectomy on ovarian reserve in patients who underwent laparoscopic hysterectomy	8
The challenge of ovarian tissue culture: 2D versus 3D culture	8
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer	8
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer	8
Small RNA sequencing reveals distinct nuclear microRNAs in pig granulosa cells during ovarian follicle growth	8
Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma	8
Ovarian metastasis from nongynecologic primary sites: a retrospective analysis of 177 cases and 13-year experience	8
Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors	8
CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3	8
The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve	8
Plumbagin rescues the granulosa cell’s pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome	8
Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review	8
Assisted hatching of vitrified-warmed blastocysts prior to embryo transfer does not improve pregnancy outcomes	8
Evaluation of mitochondria in mouse oocytes following cisplatin exposure	8
Female germline stem cells: aging and anti-aging	8
Effects and mechanisms of mUCMSCs on ovarian structure and function in naturally ageing C57 mice	8
Short (seven days) versus standard (fourteen days) oestrogen administration in a programmed frozen embryo transfer cycle: a retrospective cohort study	8
miR-4324 inhibits ovarian cancer progression by targeting FEN1	8
High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer	8
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer	8
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer	8
Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma	8
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance	8
Ovarian inguinal hernia – a possibility in MURCS syndrome	8